Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited et al
| Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals Inc. |
| Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc. and Sun Pharmaceutical Industries Limited |
| 1:2020cv01585 |
| November 23, 2020 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 21, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re (15 in 1:20-cv-01153-CFC, 14 in 1:20-cv-01585-CFC) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 27, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 1/21/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms)
|
| Filing 14 STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 27, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Filing 13 ANSWER to #11 Answer to Complaint, Counterclaim by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Limited for Ohm Laboratories, Inc., Sun Pharmaceutical Industries, Inc. filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Phillips, John) |
| Filing 11 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc..(Phillips, John) |
|
Filing 10
ORDER, on or before January 20, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/20/2021.) Signed by Judge Colm F. Connolly on 12/17/2020. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(nmf)
|
| Filing 9 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries Limited served on 12/2/2020, answer due 12/23/2020. (Dellinger, Megan) |
| Filing 8 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries, Inc. served on 12/2/2020, answer due 12/23/2020. (Dellinger, Megan) |
| Filing 7 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Ohm Laboratories, Inc. served on 12/2/2020, answer due 12/23/2020. (Dellinger, Megan) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. No for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/14/2020. Date of Expiration of Patent: 08/01/2028.Thirty Month Stay Deadline: 4/14/2023. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT filed against Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3350344.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: #1 Exhibit 1, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
